NCT05742477

Brief Summary

Determine Treatment outcome with antibiotic use and its resistance pattern among neonatal sepsis patients

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2022

Completed
6 months until next milestone

First Posted

Study publicly available on registry

February 24, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

March 31, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 24, 2023

Status Verified

February 1, 2023

Enrollment Period

1.7 years

First QC Date

August 22, 2022

Last Update Submit

February 14, 2023

Conditions

Keywords

neonatalsepsisantibiotics

Outcome Measures

Primary Outcomes (2)

  • Sepsis convelence

    It is difined by abcence of fever, jundice, respiratory failure and gastroentritis

    24hours

  • Sepsis convelence

    It is difined by abcence of fever, jundice, respiratory failure and gastroentritis

    1 week

Interventions

role of antibiotics in treatment of neonatal sepsis

Eligibility Criteria

Age1 Day - 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

patients with neonatal sepsis

You may qualify if:

  • Newborn suspected with sepsis diagnosed on the basis of clinical signs and symptoms:
  • temperature instability
  • feeding problems,
  • convulsions,
  • lethargy
  • respiratory distress.
  • laboratory findings such as:
  • C-Reactive Protein (CRP)
  • complete blood count (CBC)
  • blood/urine cultures

You may not qualify if:

  • Respiratory distress syndrome
  • Congenital pneumonia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Klein JO. Bacteriology of neonatal sepsis. Pediatr Infect Dis J. 1990 Oct;9(10):778. No abstract available.

    PMID: 2235163BACKGROUND
  • Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, Lawn JE, Cousens S, Mathers C, Black RE. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016 Dec 17;388(10063):3027-3035. doi: 10.1016/S0140-6736(16)31593-8. Epub 2016 Nov 11.

    PMID: 27839855BACKGROUND
  • Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012 Jun 9;379(9832):2151-61. doi: 10.1016/S0140-6736(12)60560-1. Epub 2012 May 11.

    PMID: 22579125BACKGROUND
  • Stoll BJ, Hansen NI, Sanchez PJ, Faix RG, Poindexter BB, Van Meurs KP, Bizzarro MJ, Goldberg RN, Frantz ID 3rd, Hale EC, Shankaran S, Kennedy K, Carlo WA, Watterberg KL, Bell EF, Walsh MC, Schibler K, Laptook AR, Shane AL, Schrag SJ, Das A, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011 May;127(5):817-26. doi: 10.1542/peds.2010-2217. Epub 2011 Apr 25.

    PMID: 21518717BACKGROUND

Related Links

MeSH Terms

Conditions

Neonatal SepsisSepsis

Interventions

Anti-Bacterial Agents

Condition Hierarchy (Ancestors)

InfectionsInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anti-Infective AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Central Study Contacts

Abd elrahman Ahmed Hussain, resident doctor

CONTACT

Naglaa Abu Fadan, Prof.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 22, 2022

First Posted

February 24, 2023

Study Start

March 31, 2023

Primary Completion

December 1, 2024

Study Completion

December 31, 2024

Last Updated

February 24, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share